Skip to main content
SpringerLink
Log in

18F Fluorodeoxyglucose PET and Thyroid Nodules

  • Chapter
  • First Online:
Thyroid Cancer

  • 172 Accesses

Abstract

The objective of this chapter is to review the 18F-FDG-PET and PET-CT detection of incidental uptake in the thyroid, the patterns of 18F-FDG-PET uptake, the significance of the standard uptake value (SUV), and the management of 18F-FDG-PET incidental thyroid lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Warburg O, Wind F, Neglers E. On the metabolism of tumors in the body. In: Warburg O, editor. Metabolism of tumors. London: Constable; 1930. p. 254–70.

    Google Scholar 

  2. Adler LP, Bloom AD. Positron emission tomography of thyroid masses. Thyroid. 1993;3:195–200.

    Article  CAS  PubMed  Google Scholar 

  3. Joensuu H, Ahonen A. Imaging of metastases of thyroid carcinoma with fluorine-18 fluorodeoxyglucose. J Nucl Med. 1987;28:910–4.

    CAS  PubMed  Google Scholar 

  4. Mitchell J, Parangi S. The thyroid incidentaloma: an increasingly frequent consequence of radiologic imaging. Semin Ultrasound CT MR. 2005;26:37–46. Review.

    Article  PubMed  Google Scholar 

  5. Chen W, Parsons M, Torigian DA, Zhuang H, Alavi A. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging. Nucl Med Commun. 2009;30:240–4.

    Article  CAS  PubMed  Google Scholar 

  6. Vriens D, de Wilt JH, van der Wilt GJ, Netea-Maier RT, Oyen WJ, de Geus-Oei LF. The role of [(18)F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature. Cancer. 2011;117:4582–94.

    Article  PubMed  Google Scholar 

  7. Gough J, Scott-Coombes D, Palazzo FF. Thyroid incidentaloma: an evidence-based assessment of management strategy. World J Surg. 2008;32:1264–8.

    Article  PubMed  Google Scholar 

  8. Van Den Bruel A, Maes A, De Potter T, Mortelmans L, Drijkoningen M, Van Damme B, Delaere P, Bouillon R. Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma. J Clin Endocrinol Metab. 2002;87:1517–20.

    Article  PubMed  Google Scholar 

  9. Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med. 1997;126:226–31.

    Article  CAS  PubMed  Google Scholar 

  10. Brander A, Viikinkoski P, Nickels J, Kivisaari L. Thyroid gland: US screening in a random adult population. Radiology. 1991;181:683–7.

    Article  CAS  PubMed  Google Scholar 

  11. Youserm DM, Huang T, Loevner LA, Langlotz CP. Clinical and economic impact of incidental thyroid lesions found with CT and MR. Am J Neuroradiol. 1997;18:1423–8.

    CAS  PubMed  Google Scholar 

  12. Nishimori H, Tabah R, Hickeson M, How J. Incidental thyroid “PETomas”: clinical significance and novel description of the self-resolving variant of focal thyroid uptake. Can J Surg. 2011;54:83–8.

    Google Scholar 

  13. Pak K, Kim SJ, Kim IJ, et al. The role of 18F-fluorodeoxyglucose positron emission tomography in differentiated thyroid cancer before surgery. Endocr Relat Cancer. 2013;20:R203–13.

    Article  CAS  PubMed  Google Scholar 

  14. Are C, Hsu JF, Schoder H, et al. FDG-PET detected thyroid incidentalomas: need for further investigation? Ann Surg Oncol. 2007;14:239–47.

    Article  PubMed  Google Scholar 

  15. Kim TY, Kim WB, Ryu JS, Gong G, Hong SJ, Shong YK. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope. 2005;115:1074–8.

    Article  PubMed  Google Scholar 

  16. Are C, Hsu JF, Ghossein RA, et al. Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carcinomas. Ann Surg Oncol. 2007;14:3210–5.

    Article  PubMed  Google Scholar 

  17. Shiea P, Cardarellib R, Sprawlsb K, Fuldab KG, Taur A. Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography. Nucl Med Commun. 2009;30:742–8.

    Article  Google Scholar 

  18. Mazzaferri EL. Current concepts: management of a solitary thyroid nodule. N Engl J Med. 1993;328:553–9.

    Article  CAS  PubMed  Google Scholar 

  19. Steele SR, Martin MJ, Mullenix PS, et al. The significance of incidental thyroid abnormalities identified during carotid duplex ultrasonography. Arch Surg. 2005;140:981–5.

    Article  PubMed  Google Scholar 

  20. Shetty SK, Maher MM, Hahn PF, et al. Significance of incidental thyroid lesions detected on CT: correlation among CT, sonography, and pathology. AJR. 2006;187:1349–56.

    Article  PubMed  Google Scholar 

  21. Yi JG, Marom EM, Munden RF, Truong MT, Macapinlac HA, Gladish GW, Sabloff BS, Podoloff DA. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non–small cell lung cancer. Radiology. 2005;236:271–5.

    Article  PubMed  Google Scholar 

  22. Kang KW, Kim SK, Kang HS, et al. Prevalence and risk of cancer of focal thyroid incidentalomas identified by 18F-Fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab. 2003;88:4100–4.

    Article  CAS  PubMed  Google Scholar 

  23. Cohen MS, Arslan N, Dehdashti F, Doherty G, Lairmore TC, Brunt M, Moley JF. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery. 2001;130:941–6.

    Article  CAS  PubMed  Google Scholar 

  24. Frates MC, Benson CB, Charboneau JW, et al. Management of thyroid nodules detected at US, Society of Radiologists in Ultrasound consensus conference statement. Ultrasound Q. 2006;22:231–8.

    Article  PubMed  Google Scholar 

  25. Even-Sapir E, Lerman H, Gutman M, Lievshitz G, Zuriel L, Polliack A, et al. The presentation of malignant tumours and pre-malignant lesions incidentally found on PET-CT. Eur J Nucl Med Mol Imaging. 2006;33:541–52.

    Article  PubMed  Google Scholar 

  26. Bae JS, Chae BJ, Park WC, Kim JS, Kim SH, Jung SS, Song BJ. Incidental thyroid lesions detected by FDG-PET/CT: prevalence and risk of thyroid cancer. World J Surg Oncol. 2009;7:63.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Bertagna F, Treglia G, Piccardo A, et al. F18-FDG-PET/CT thyroid incidentalomas: a wide retrospective analysis in three Italian centres on the significance of focal uptake and SUV value. Endocrine. 2013;43:678–85.

    Article  CAS  PubMed  Google Scholar 

  28. Bogsrud TV, Karantanis D, Nathan MA, et al. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT. Nucl Med Commun. 2007;28:373–81.

    Article  PubMed  Google Scholar 

  29. Ishimori T, Patel PV, Wahl RL. Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med. 2005;46:752–7.

    PubMed  Google Scholar 

  30. Nakhjavani MK, Gharib H, Goellner JR, van Heerden JA. Metastasis to the thyroid gland: a report of 43 cases. Cancer. 1997;79:574–8.

    Article  CAS  PubMed  Google Scholar 

  31. Katz SC, Shaha A. PET-associated incidental neoplasms of the thyroid. J Am Coll Surg. 2008;207:259–64.

    Article  PubMed  Google Scholar 

  32. Ho TY, Liou MJ, Lin KJ, Yen TC. Prevalence and significance of thyroid uptake detected by (18)F-FDG PET. Endocrine. 2011;40:297–302.

    Article  CAS  PubMed  Google Scholar 

  33. Basu S, Alavi A. Metastatic malignant melanoma to the thyroid gland detected by FDG-PET imaging. Clin Nucl Med. 2007;32:388–9.

    Article  PubMed  Google Scholar 

  34. Chung AY, Tran TB, Brumund KT, Weisman RA, Bouvet M. Metastases to the thyroid: a review of the literature from the last decade. Thyroid. 2012;22:258–68.

    Article  PubMed  Google Scholar 

  35. Singh R, Lehl SS, Sachdev A, Handa U, D’Cruz S, Bhalla A. Metastasis to thyroid from lung carcinoma. Indian J Chest Dis Allied Sci. 2003;45:203–4.

    CAS  PubMed  Google Scholar 

  36. Choi JY, Lee KS, Kwon OJ, et al. Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging. J Clin Oncol. 2005;23:7654–9.

    Article  PubMed  Google Scholar 

  37. Eloy JA, Brett EM, Fatterpekar GM, Kostakoglu L, Som PM, Desai SC, Genden EM. The significance and management of incidental [18F]fluorodeoxyglucose–positron-emission tomography uptake in the thyroid gland in patients with cancer. AJNR Am J Neuroradiol. 2009;30:1431–4.

    Article  CAS  PubMed  Google Scholar 

  38. Kresnik E, Gallowitsch HJ, Mikosch P, et al. Fluorine-18-fluorodeoxyglusocse positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area. Surgery. 2003;133:294–9.

    Article  PubMed  Google Scholar 

  39. Petrich T, Borner AR, Otto D, et al. Influence of rhTSH on [(18)F]fluorodeoxyglucose uptake by differentiated thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2002;29:641–7.

    Article  CAS  PubMed  Google Scholar 

  40. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM, The American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167.

    Article  PubMed  Google Scholar 

  41. National Comprehensive Cancer Network (NCCN) Guidelines in oncology. Thyroid Carcinoma. Version 3.2013.

    Google Scholar 

  42. Deandreis D, Al Ghuzlan A, Auperin A, Vielh P, Caillou B, Chami L. Is 18F-fluorodeoxyglucose-PET/CT useful for presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology? Thyroid. 2012;22:165–72.

    Article  CAS  PubMed  Google Scholar 

  43. Law TT, Hung-Hin Lang B. Incidental thyroid carcinoma by FDG-PET/CT: a study of clinicopathological characteristics. Ann Surg Oncol. 2011;18:472–8.

    Article  CAS  PubMed  Google Scholar 

  44. Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg. 2010;34:28–35.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nuclear Medicine, Department of Medicine, MedStar Washington Hospital Center/Georgetown University, 110 Irving Street, NW, Suite GB-01, Washington, DC, 20010, USA

    Carlos Alberto Garcia MD

Authors
  1. Carlos Alberto Garcia MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carlos Alberto Garcia MD .

Editor information

Editors and Affiliations

  1. Department of Medicine, MedStar Washington Hospital Center Georgetown University School of Medicine, Washington, DC, USA

    Leonard Wartofsky

  2. Nuclear Medicine Research MedStar Research Institute and Washington Hospital Center, Georgetown University School of Medicine Washington Hospital Center, Washington, DC, USA

    Douglas Van Nostrand

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

Garcia, C.A. (2016). 18F Fluorodeoxyglucose PET and Thyroid Nodules. In: Wartofsky, L., Van Nostrand, D. (eds) Thyroid Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3314-3_25

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3314-3_25

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-3312-9

  • Online ISBN: 978-1-4939-3314-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation